EPIRUS Biopharmaceuticals, Inc. Aktie

Aktien

Verzögert OTC Markets Andere Börsenplätze			% 5 Tage	% 1. Jan.
- ^USD	-.--%		-.--%	-.--%

2016	Transcript : EPIRUS Biopharmaceuticals, Inc., Q4 2015 Earnings Call, Mar 15, 2016
2015	Transcript : EPIRUS Biopharmaceuticals, Inc., Q3 2015 Earnings Call, Nov 16, 2015

Dauer

Zeitraum

Stil

Transcript : EPIRUS Biopharmaceuticals, Inc., Q4 2015 Earnings Call, Mar 15, 2016	15.03.16
Transcript : EPIRUS Biopharmaceuticals, Inc., Q3 2015 Earnings Call, Nov 16, 2015	16.11.15
Transcript : EPIRUS Biopharmaceuticals, Inc. Presents at Wedbush PacGrow Healthcare Conference 2015, Aug-11-2015 01:20 PM	11.08.15
Transcript : EPIRUS Biopharmaceuticals, Inc., Zalicus Inc. - M&A Call	16.04.14

Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	09.10.18
Praxis Precision Medicines, Inc. completed the acquisition of Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q).	31.01.18
Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	19.01.18
Praxis Precision Medicines, Inc. agreed to acquire Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q) for $1 million.	18.01.18
Notice of Intent of Asset Sale Filed by EPIRUS Biopharmaceuticals, Inc.	11.12.17

EPIRUS Biopharmaceuticals, Inc. befindet sich im Konkursverfahren.

Sektor

	% 1. Jan.	Kap.
EPIRUS BIOPHARMACEUTICALS, INC.	-.--%	26
MODERNA, INC.	+43,36 %	54,64 Mrd.
IQVIA HOLDINGS INC.	-5,31 %	39,92 Mrd.
LONZA GROUP AG	+37,52 %	38,82 Mrd.
ICON PUBLIC LIMITED COMPANY	+14,75 %	26,86 Mrd.
CELLTRION, INC.	-12,56 %	26,22 Mrd.
ALNYLAM PHARMACEUTICALS, INC.	-22,45 %	18,78 Mrd.
BIO-TECHNE CORPORATION	+0,04 %	12,16 Mrd.
UNITED THERAPEUTICS CORPORATION	+25,12 %	12,21 Mrd.
MEDPACE HOLDINGS, INC.	+26,04 %	11,94 Mrd.